Abstract
The biochemical events responsible for the progression of normal melanocytes into preneoplastic cells, such as in dysplastic nevi, and further on into early malignant state such as in thin-radial melanoma, into nodular melanoma and culminating in metastatic disease are not yet known. One of the most common characteristics of melanoma cells grown in vitro from nodular primary or metastatic melanoma lesions is an acquired autonomy from growth factors required by their normal counterparts and possibly by melanocytes from primary melanomas of the radial growth phase. In view of the fact that normal human melanocytes depend on several growth factors, it is possible that progression to melanoma is due to inappropriate production of one or more of these factors, to mutations that cause constitutive activation of the receptors for these growth factors, or to constitutive activation of other components of the signal transduction pathway. Therefore knowledge of growth factors/receptors and their substrates operative in normal human melanocytes may provide clues for the biochemical basis of transformation to melanomas. The following review focuses on growth factor and receptor activity in normal and malignant melanocytes.
A version of this article appeared in Critical Reviews in Oncogenesis (Halaban and Moellmann 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adelaide J, Mattei M-G, Marics I, Raybaud F, Planche J, De Lapeyriere O, Birnbaum D (1988) Chromosomal localization of the hst oncogene and its coamplification with the int.2 oncogene in human melanoma. Oncogene 2:413–416
Ahn NG, Krebs EG (1990) Evidence for an epidermal growth factor-stimulated protein kinase cascade in Swiss 3T3 cells. J Biol Chem 265:11495–11501
Albino AP, Davis BM, Nanus DM (1991) Induction of growth Factor RNA expression in human malignant melanoma:markers of transformation. Cancer Res 51:4815–4820
Anders F, Schartl M, Barnekow A, Anders A (1984) Xiphophorus as an in vivo model for studies on normal and defective control of oncogenes. Adv Cancer Res 42:191–275
Anderson DM, Lyman SD, Baird A, Wignall J, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DD (1990a) Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235–243
Anderson NG, Mailer JL, Tonks NK, Sturgill TW (1990b) Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343:651–653
Anderson NG, Li P, Marsden LA, Williams N, Roberts TM, Sturgill TW (1991) Raf-1 is a potential substrate for mitogen-activated protein kinase in vivo. Biochem J 277:573–576
Avivi A, Zimmer Y, Yayon A, Yarden Y, Givol D (1991) Flg-2, a new member of the family of fibroblast growth factor receptors. Oncogene 6:1089–1092
Balaban G, Herlyn M, Guerry IV D, Bartolo R, Koprowski H, Clark WH, Nowell PC (1984) Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11:429–439
Baldin V, Roman A-M, Bosc-Bierne I, Almaric F, Bouche G (1990) Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J 9:1511–1517
Becker D, Meier CB, Herlyn M (1989) Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685–3691
Becker D, Lee PL, Rodeck U, Herlyn M (1992) Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7:2303–2313
Berridge MJ, Irvine RF (1984) Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312:315–320
Barnard O, Li M, Reid HH (1991) Expression of two different forms of fibroblast growth factor receptor 1 in different mouse tissues and cell lines. Proc Natl Acad Sci USA 88:7625–7629
Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA (1990) Characterization of the receptor for keratinocyte growth factor. J Biol Chem 265:12767–12770
Bottaro DP, Rubin JS, Faletto DL, Chan A, M-L, Kmiecik TE, Vande Woude GP, Aaronson SA (1991) Identification of the HGF receptor as the c-met protooncogene product. Science 251:802–804
Boulton TG, Cobb MH (1991) Identification of multiple extracellular signal- regulated kinases ( ERKs) with antipeptide antibodies. Cell Regul 2:357–371
Boulton TG, Gregory JS, Cobb MH (1991a) Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubuleassociated protein 2 kinase. Biochemistry 30:278–286
Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, GD, Yancopoulos GD (1991b) ERKs:a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675
Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson D, Cosman D, Bedell MA, Jenkins NA, Copeland NG (1991) Steel-Dickie mutation encodes a c-Kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 88:4671–4674
Burgess WH, Dionne CA, Kaplow J, Mudd R, Friesel R, Zilberstein A, Schlessinger J, Jaye M (1990) Characterization and cDNA cloning of phospholipase C-g, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Mol Cell Biol 10:4770–4777
Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991) Oncogenes and signal transduction. Cell 64:281–302
Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstei A (1988) The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88–89
Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33
Copeland N, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DE (1990) Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175–183
Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J (1991) Fibroblast cell interactions with human melanoma cells affect tumor growth as a function of tumor progression. Proc Natl Acad Sci USA 88:6028–6032
Coughlin SR, Barr PJ, Cousens LS, Fretto LJ, Williams LT (1988) Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. J Biol Chem 263:988–993
Cowan JM, Francke U (1991) Cytogenetic analysis in melanoma and nevi. In: Nathanson L (ed) Melanoma research:genetics, growth factors, metastases, and antigens. Kluwer, Boston, pp 3–16
Cowan JM, Halaban R, Francke U (1988) Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80:1159–1164
Cuadrado A, Molloy CJ (1990) Overexpression of phospholipase C-y in NIH 3T3 fibroblasts results in increased phosphatidylinositol hydrolysis in response to platelet-derived growth factor and basic fibroblast growth factor. Mol Cell Biol 10:6069–6072
De Luca M, D’Anna F, Bondanza S, Franzi AT, Cancedda R (1988) Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J Cell Biol 107:1919–1926
Delli Bovi P, Basilico C (1987) Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad Sci USA 84:5660–5664
Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J (1990) Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9:2685–2692
Dotto P, Moellmann G, Ghosh S, Edwards M, Halaban R (1989) Transformation of murine melanocytes with basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 109:3115–3128
Eiseman A, Ahn JA, Graciani G, Tronick SR, Ron D (1991) Alternative splicing generates at least 5 different isoforms of the human bFGF-receptor. Oncogene 6:1195–1202
Fischer EH, Charbonneau H, Tonks NK (1991) Protein kinase phosphatases:a diverse family of intracellular and transmembrane enzymes. Science 253:401–406
Flanagan JG, Leder P (1990) The kit ligand:a cell surface molecule altered in steel mutant fibroblasts. Cell 63:185–194
Flanagan JG, Chan DG, Leder P (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sl d mutant. Cell 64:1025–1035
Fleischman RA (1992) Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest 89:1713–1717
Fleischman RA, Saltman DL, Stastny V, Zneimer S (1991) Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proc Natl Acad Sci USA 88:10885–10889
Fougère C, Ruiz F, Ephrussi B (1972) Gene dosage dependence of pigment synthesis in melanoma x fibroblast hybrids. Proc Natl Acad Sci USA 69:330–334
Friesel R, Burgess WH, Maciag T (1989) Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells. Mol Cell Biol 9:1857–1865
Funasaka Y, Boulton T, Cobb M, Yosef Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y, Halaban (1992) C-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human protein melanocytes in response to mast cell growth factor and stimulates mitogen-activated kinase but is down regulated in melanomas. Mol Biol Cell 3:197–209
Geissler EN, Ryan MA, Housman DE (1988) The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185–192
Gerschenson M, Graves K, Carson SD, Wells RS, Pierce B (1986) Regulation of melanoma by the embryonic skin. Proc Natl Acad Sci USA 83:7307–7310
Gherardi E, Stoker M (1991) Hepatocyte growth factor-scatter factor:mitogen, motogen, and met. Cancer Cells 3:227–232
Giebel LB, Spritz RA (1991) Mutation of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Proc Natl Acad Sci USA 88:8696–8699
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102:458–465
Gregory J, Boulton T, Sang BC, Cobb J (1989) An insulin-stimulated ribosomal protein S6 kinase from rabbit liver. J Biol Chem 264:18377–18401
Halaban R (1988) Responses of cultured melanocytes to defined growth factors. Pigm Cell Res 1:18–26
Halaban R (1989) Growth regulation in normal and malignant melanocytes. In: Ferrone S (ed) Human melanoma. Springer, Berlin Heidelberg New York, pp 3–14
Halaban R (1991) The regulatory role of fibroblast growth factor in melanomas. In: Nathanson L (ed) Melanoma 5. Kluwer, Norwell, pp 19–40 (Cancer treatment and research series)
Halaban R, Moellmann G (1991) Proliferation and malignant transformation of melanocytes. Crit Rev Oncogen 2:247–258
Halaban R, Moellmann G, Godawska E, Eisenstadt J (1980) Pigmentation and tumorigenicity of reconstituted, cybrid and hybrid mouse cells. Exp Cell Res 130:427–435
Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB (1983) Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 97:480–488
Halaban R, Ghosh S, Baird A (1987) FGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol 23:47–52
Halaban R, Langdon R, Birchall N, Cuono C, Baird A, Scott G, Moellmann G, McGuire J (1988b) Basic fibroblast growth factor of keratinocytes is a natural mitogen for normal human melanocytes. J Cell Biol 107:1611–1619
Halaban R, Funasaka Y, Lee P, Rubin J, Ron D, Birnbaum D (1991) Fibroblast growth factors in normal and malignant melanocytes. Ann NY Acad Sci 638:232–243
Halaban R, Rubin J, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W, Cook C, Moellmann G (1992) Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195–2206
Halaban R, Tyrrell L, Longley J, Yarden Y, Rubin J (1993) Pigmentation and Proliferation of Human Melanocytes and the Effect of MSH and UVB Light. Ann NY Acad Sci (in press)
Huang E, Nocka K, Beier DR, Chu T-Y, Buck J, Lahm H-W, Wellner D, Leder P, Besmer P (1990) The hematopoietic growth factor KL is encoded at the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225–233
Huang SS, Huang JS (1986) Association of bovine brain-derived growth factor receptor with protein tyrosine kinase activity. J Biol Chem 261:9568–9571
Hunter T (1989) Protein-tyrosine phosphatases:the other side of the coin. Cell 58:1013–1016
Imamura T, Tokita Y, Mitsui Y (1988) Purification of basic FGF receptors from rat brain. Biochem Biophys Res Commun 155:583–590
Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roder D, Jackson A, Mailer JAM, Hla T, Maciag T (1990) Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567–1570
Isacchi A, Statuto M, Chiesa R, Bergonzoni L, Rusnati PS, Ragnotti G, Presta M (1991) A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc Natl Acad Sci USA 88:2628–2633
Iwamoto T, Takahashi M, Ito M, Hamatani K, Ohbayashi M, Wajjwalku W, Isobe K, Nakashima I (1991) Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J 10:3167–3175
Johnson DE, Lee PL, Lu J, Williams LT (1990) Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 10:4728–4736
Kawakami M, Nishida E, Tobe K, Hoshi M, Kadowaki T, Kasuga M, Sakai H (1991) Activation of MAP kinase and enhanced phosphorylation of the 350-kDa protein by mitogenic stimuli in quiescent Balb/3 3T3 cells. Exp Cell Res 193:120–126
Keegan K, Johnson DE, Williams LT, Hayman MJ (1991) Isolation of additional member of the fibroblasts growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 88:1095–1099
Kiefer MC, Stephans JC, Crawford K, Okino K, Barr PH (1990) Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc Natl Acad Sci USA 87:6985–6989
Kwon BS, Halaban R, Kim GS, Usack L, Pomerantz S, Haq AK (1987) A melanocyte-specific cDNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine. Mol Biol Med 4:339–355
Kwon BS, Wakulchik M, Haq AK, Halaban R, Kestler D (1988) Sequence analysis of murine tyrosinase cDNA and the effect of melanotropin on its gene expression. Biochem Biophys Res Commun 153:1301–1309
Lafage-Pochitaloff M, Galland F, Simonetti J, Prats H, Mattei M-G, Birnbaum D (1990) The human basic fibroblast growth factor gene is located on the long arm of chromosome 4 bands q26—q27. Oncogene Res 5:241–244
Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT (1989) Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245:57–60
Lee R-M, Cobb MH, Blackshear PJ (1992) Evidence that extracellular signal-regulated kinases (ERKs) are the insulin-activated Raf-1 kinase kinases. J Biol Chem 267:1088–1092
Leone V, Flatow U, King CR, Sandee MA, Margulies IMK, Liotta LA, Steeg PS (1991) Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25–35
Lev S, Yarden Y, Givol D (1990) Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene. Mol Cell Biol 10:6064–6068
Lobb R, Sasse J, Sullivan R, Shing Y, D’Amore P, Jacobs J, Klagsbrun M (1986) Purification and characterization of heparin-binding endothelial cell growth factors. J Biol Chem 261:1924–1926
Lu C, Vickers MF, Kerbel RS (1992) Interleukin 6:a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 89:9215–9219
Martin FH, Sugs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher E, Erjavec HO, Herrera CH, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Zsebo K (1990) Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203–210
Matsumoto K, Tajima H, Nakamura T (1991) Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun 17:45–51
Mergia A, Eddy R, Abraham JA, Fiddes JC, Shows TB (1986) The genes for basic and acidic fibroblast growth factors are on different human chromosomes. Biochem Biophys Res Commun 138:644–651
Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson C (1986) Sequence, typography and protein coding potential of mouse int-2:a putative oncogene activated by mouse mammary tumour virus. EMBO J 5:919–924
Moscatelli D, Presta M, Joseph-Silverstein J, Rifkin DB (1986) Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol 129:273–276
Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michaolopoulos GK, Comoglio PM (1991) Hepatocyte growth factor ( HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene 6:501–504
Neufeld G, Gospodarowicz D (1985) The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol Chem 260:13860–13868
Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice — evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816–826
Nocka K, Tan JC, Chiu E, Chu TY, Ray P, Traktman P, Besmer P (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/ white spotting locus:W37 Wv, W41 and W. EMBO J 9:1805–1813
Ogata S, Furuhashi Y, Eisinger M (1987) Growth stimulation of human melanocytes:identification and characterization of melanoma-derived growth factor ( MMcGF ). Biochem Biophys Res Commun 146:1204–1211
Partanen J, Mäkelä TP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, Alitalo K (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10:1347–1354
Presta M, Maier JAM, Ragnotti G (1989) The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Cell Biol 109:1877–1884
Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670–674
Qiu F, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P (1988) Primary structure of c-kit:relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and c-terminus. EMBO J 7:1003–1011
Quarto N, Finger FP, Rifkin DB (1991) The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147:311–318
Rapraeger AC, Krufka A, Olwin BB (1991) Requirement of heparan for bFGF- mediated fibroblast growth and myoblast differentiation. Science 252:1705–1708
Reith AD, Rottapel R, Giddens E, Brady C, Forrester L, Bernstein A (1990) W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit transmembrane receptor. Genes Dev 4:390–400
Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, Herlyn M (1991) Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97:20–26
Rubin JS, Chan AM-L, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield WD, Wong J, Miki T, Finch PW, Aaronson SA (1991) A broad spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88:415–419
Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaplow J, Crumley G, Dionne C, Jaye M, Schlessinger J (1989) Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fins-like gene ( FLG ). Proc Natl Acad Sci USA 86:8722–8726
Safran A, Avivi A, Orr-Urtereger A, Neufeld G, Lonai P, Givol D, Yarden Y (1990) The murine fig gene encodes a receptor for fibroblast growth factor. Oncogene 5:635–643
Sakagushi K, Yanagishita M, Takeuchi Y, Auerbach GD (1991) Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line. J Biol Chem 266:7270–7278
Sargent NS, Oestreicher M, Haidvogl H, Madnick HM, Burger MM (1988) Growth regulation of cancer metastases by their host organ. Proc Natl Acad Sci USA 85:7251–7255
Schulze-Osthoff K, Risau W, Vollmer E, Clemens S (1990) In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 173:85–92
Scott GA, Haak A (1991) Keratinocytes regulate melanocyte number in human fetal and neonatal skin Equivalent. J Invest Dermatol 97:776–781
Scott G, Stoler M, Sarkar S, Halaban R (1991) Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J Invest Dermatol 96:318–322
Spritz RA, Giebel LB, Holmes SA (1992a) Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 50:261–269
Spritz RA, Droetto S, Fukushima Y (1992b) Deletion of the kit and Pdgfra genes in a patient with piebaldism. Am J Hum Genet (in press)
Stocker KM, Sherman L, Rees S, Ciment G (1991) Basic FGF and TGF-31 influence commitment to melanogenesis in neural crest-derived cells of avian embryos. Development 111:635–641
Straus DS, Jonasson J, Harris H (1976) Growth in vitro of tumor cell x fibroblast hybrids in which malignancy is suppressed. J Cell Sci 25:73–86
Sturgill TW, Ray B, Erikson E, Mailer JL (1988) Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715–718
Takahashi M, Buma Y, Taniguchi M (1990) Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene 5:126–130
Tan JC, Nocka K, Ray P, Traktman P, Besmer P (1990) The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209–212
Tessler S, Neufeld G (1990) Basic fibroblast growth factor accumulates in the nuclei of various bFGF producing cell types. J Cell Physiol 145:310–317
Theillet C, Le Roy X, De Lapeyrière O, Grosgeorges J, Adnane J, Raynaud SD, Simony-Lafontaine J, Goldfarb M., Escot C, Birnbaum D, Gaudray P (1989) Amplification of FGF-related genes in human tumors:possible involvement of HST in breast carcinomas. Oncogene 4:915–922
Trent JM, Meyskens FL, Salmon SE, Ryschon K, Leong SPL, Davis JR, McGee DL (1990a) Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N Engl J Med 322:1508–1511
Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB (1990b) Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247:568–571
Wakeling WF, Greetham LM, Bennett DC (1992) Suppression of properties associated with malignancy in murine melanoma-melanocyte hybrid cells. Br J Cancer 65:529–537
Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GM, Cosman D, Lyman SD (1990) Identification of a ligand for the c-kit proto-oncogene. Cell 63:167–174
Wittbrodt J, Adam D, Malitschek B, Mäueler W, Raulf F, Telling A, Robertson SM, Schartl M (1989) Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature 341:415–421
Yarden Y, Ullrich A (1988) Growth factor receptor tyrosine kinases. Ann Rev Biochem 57:443–478
Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A (1987) Human proto-oncogene c-kit:a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341–3351
Yayon A, Klagsbrun M, Esko J, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841–848
Zakut R, Perlis R, Eliahu S, Yarden Y, Givol D, Lyman SD, Halaban R (1993) KIT-ligand (cast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene (in press)
Zsebo K, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs S (1990a) Stern cell factor is encoded at the Si locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213–224
Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sadchev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE (1990b) Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195–201
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Halaban, R. (1993). Growth Regulation in Normal and Malignant Melanocytes. In: Hecker, E., Jung, E.G., Marks, F., Tilgen, W. (eds) Skin Carcinogenesis in Man and in Experimental Models. Recent Results in Cancer Research, vol 128. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84881-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-84881-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84883-4
Online ISBN: 978-3-642-84881-0
eBook Packages: Springer Book Archive